• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视黄醇脱氢酶-10通过TWEAK-NF-κB轴促进人类胶质瘤的发生发展。

Retinol dehydrogenase-10 promotes development and progression of human glioma via the TWEAK-NF-κB axis.

作者信息

Guan Feng, Wang Liang, Hao Shuyu, Wu Zhen, Bai Jian, Kang Zhuang, Zhou Quan, Chang Hong, Yin Hui, Li Da, Tian Kaibin, Ma Junpeng, Zhang Guijun, Zhang Junting

机构信息

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.

出版信息

Oncotarget. 2017 Oct 27;8(62):105262-105275. doi: 10.18632/oncotarget.22166. eCollection 2017 Dec 1.

DOI:10.18632/oncotarget.22166
PMID:29285249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5739636/
Abstract

Retinol dehydrogenase-10 (RDH10) is a member of the short-chain dehydrogenase/reductase family, which plays an important role in retinoic acid (RA) synthesis. Here, we show that RDH10 is highly expressed in human gliomas, and its expression correlates with tumor grade and patient survival times. , lentivirus-mediated shRNA knockdown of RDH10 suppressed glioma cell proliferation, survival, and invasiveness and cell cycle progression. , RDH10 knockdown reduced glioma growth in nude mice. Microarray analysis revealed that RDH10 silencing reduces expression of TNFRSF12A (Fn14), TNFSF12 (TWEAK), TRAF3, IKBKB (IKK-β), and BMPR2, while it increases expression of TRAF1, NFKBIA (IκBα), NFKBIE (IκBε), and TNFAIP3. This suggests that RDH10 promotes glioma cell proliferation and survival by regulating the TWEAK-NF-κB axis, and that it could potentially serve as a novel target for human glioma treatment.

摘要

视黄醇脱氢酶10(RDH10)是短链脱氢酶/还原酶家族的一员,在视黄酸(RA)合成中起重要作用。在此,我们发现RDH10在人类胶质瘤中高表达,其表达与肿瘤分级和患者生存时间相关。慢病毒介导的RDH10的短发夹RNA敲低抑制了胶质瘤细胞的增殖、存活、侵袭以及细胞周期进程。RDH10敲低降低了裸鼠体内胶质瘤的生长。基因芯片分析显示,RDH10沉默降低了TNFRSF12A(Fn14)、TNFSF12(TWEAK)、TRAF3、IKBKB(IKK-β)和BMPR2的表达,而增加了TRAF1、NFKBIA(IκBα)、NFKBIE(IκBε)和TNFAIP3的表达。这表明RDH10通过调节TWEAK-NF-κB轴促进胶质瘤细胞的增殖和存活,并且它可能潜在地成为人类胶质瘤治疗的新靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/f499965dee45/oncotarget-08-105262-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/a59f50993a7c/oncotarget-08-105262-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/eda1ddbc4987/oncotarget-08-105262-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/8152366f6b4a/oncotarget-08-105262-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/c10cd807ca25/oncotarget-08-105262-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/909afd5dfca5/oncotarget-08-105262-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/0cff5adce45a/oncotarget-08-105262-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/f499965dee45/oncotarget-08-105262-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/a59f50993a7c/oncotarget-08-105262-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/eda1ddbc4987/oncotarget-08-105262-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/8152366f6b4a/oncotarget-08-105262-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/c10cd807ca25/oncotarget-08-105262-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/909afd5dfca5/oncotarget-08-105262-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/0cff5adce45a/oncotarget-08-105262-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9210/5739636/f499965dee45/oncotarget-08-105262-g007.jpg

相似文献

1
Retinol dehydrogenase-10 promotes development and progression of human glioma via the TWEAK-NF-κB axis.视黄醇脱氢酶-10通过TWEAK-NF-κB轴促进人类胶质瘤的发生发展。
Oncotarget. 2017 Oct 27;8(62):105262-105275. doi: 10.18632/oncotarget.22166. eCollection 2017 Dec 1.
2
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.肿瘤坏死因子样凋亡微弱诱导剂(TWEAK)通过诱导NF-κB诱导激酶(NIK)和非经典NF-κB信号传导促进胶质瘤细胞侵袭。
Mol Cancer. 2015 Jan 27;14(1):9. doi: 10.1186/s12943-014-0273-1.
3
Elevated fibroblast growth factor-inducible 14 expression transforms proneural-like gliomas into more aggressive and lethal brain cancer.成纤维细胞生长因子诱导 14 表达升高将神经前体细胞样神经胶质瘤转化为侵袭性和致命性脑癌。
Glia. 2021 Sep;69(9):2199-2214. doi: 10.1002/glia.24018. Epub 2021 May 15.
4
Retinol dehydrogenase 10 promotes metastasis of glioma cells via the transforming growth factor-β/SMAD signaling pathway.视黄醇脱氢酶 10 通过转化生长因子-β/SMAD 信号通路促进神经胶质瘤细胞的转移。
Chin Med J (Engl). 2019 Oct 20;132(20):2430-2437. doi: 10.1097/CM9.0000000000000478.
5
Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome.成纤维细胞生长因子诱导14表达水平升高通过Rac1和核因子κB促进胶质瘤细胞侵袭,并与患者预后不良相关。
Cancer Res. 2006 Oct 1;66(19):9535-42. doi: 10.1158/0008-5472.CAN-06-0418.
6
FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.成纤维细胞生长因子诱导的 14kDa 蛋白(Fn14)在心肌细胞中通过 RhoA/ROCK 激酶途径调节,并通过 TWEAK 介导核因子-κB 的激活。
Basic Res Cardiol. 2010 Mar;105(2):301-13. doi: 10.1007/s00395-009-0046-y. Epub 2009 Jul 23.
7
TWEAK promotes ovarian cancer cell metastasis via NF-kappaB pathway activation and VEGF expression.肿瘤坏死因子样弱凋亡诱导因子通过激活核因子κB通路和血管内皮生长因子表达促进卵巢癌细胞转移。
Cancer Lett. 2009 Oct 8;283(2):159-67. doi: 10.1016/j.canlet.2009.03.036. Epub 2009 Apr 23.
8
Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis.TWEAK/Fn14 在神经母细胞瘤中的表达:在肿瘤发生中的意义。
Int J Oncol. 2013 Apr;42(4):1239-48. doi: 10.3892/ijo.2013.1800. Epub 2013 Jan 29.
9
Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.肿瘤坏死因子α与凋亡的肿瘤坏死因子样弱诱导剂协同作用导致小鼠急性结肠炎中经典核因子κB的病理激活。
Cytokine. 2014 Sep;69(1):14-21. doi: 10.1016/j.cyto.2014.05.001. Epub 2014 May 27.
10
ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals.ALKBH3 通过 NADPH 氧化酶和 tweak/Fn14/VEGF 信号促进人尿路上皮癌细胞的存活和血管生成。
Clin Cancer Res. 2012 Oct 1;18(19):5247-55. doi: 10.1158/1078-0432.CCR-12-0955. Epub 2012 Jul 31.

引用本文的文献

1
Identification of prognostic biomarkers related to retinoic acid metabolism in gliomas and analysis of their impact on the immune microenvironment.鉴定与胶质瘤中维甲酸代谢相关的预后生物标志物,并分析它们对免疫微环境的影响。
Medicine (Baltimore). 2024 Oct 11;103(41):e39836. doi: 10.1097/MD.0000000000039836.
2
Retinol dehydrogenase 10 promotes epithelial-mesenchymal transition in spinal cord gliomas via PI3K/AKT pathway.视黄醇脱氢酶 10 通过 PI3K/AKT 通路促进脊髓神经胶质瘤中的上皮-间充质转化。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241276336. doi: 10.1177/03946320241276336.
3
Comprehensive analysis of pyroptosis-related gene signatures for glioblastoma immune microenvironment and target therapy.

本文引用的文献

1
Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.金精三羧酸作为胶质母细胞瘤细胞中TWEAK-Fn14信号通路的选择性抑制剂的鉴定。
Oncotarget. 2017 Feb 14;8(7):12234-12246. doi: 10.18632/oncotarget.14685.
2
GE-mini: a mobile APP for large-scale gene expression visualization.GE-mini:一款用于大规模基因表达可视化的移动应用程序。
Bioinformatics. 2017 Mar 15;33(6):941-943. doi: 10.1093/bioinformatics/btw775.
3
TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion.
胶质母细胞瘤免疫微环境和靶向治疗相关焦亡基因特征的综合分析。
Cell Prolif. 2023 Mar;56(3):e13376. doi: 10.1111/cpr.13376. Epub 2023 Jan 21.
4
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma.卵巢透明细胞癌中的抗氧化剂与治疗靶点
Antioxidants (Basel). 2021 Jan 28;10(2):187. doi: 10.3390/antiox10020187.
5
Retinol dehydrogenase 10 promotes metastasis of glioma cells via the transforming growth factor-β/SMAD signaling pathway.视黄醇脱氢酶 10 通过转化生长因子-β/SMAD 信号通路促进神经胶质瘤细胞的转移。
Chin Med J (Engl). 2019 Oct 20;132(20):2430-2437. doi: 10.1097/CM9.0000000000000478.
6
Ginkgo Flavonol Glycosides or Ginkgolides Tend to Differentially Protect Myocardial or Cerebral Ischemia-Reperfusion Injury Regulation of TWEAK-Fn14 Signaling in Heart and Brain.银杏黄酮醇苷或银杏内酯倾向于差异性地保护心肌或脑缺血再灌注损伤 心脏和大脑中TWEAK-Fn14信号通路的调控。
Front Pharmacol. 2019 Jul 5;10:735. doi: 10.3389/fphar.2019.00735. eCollection 2019.
肿瘤坏死因子样弱凋亡诱导因子(TWEAK)激活非经典核因子κB(NF-κB)信号通路对黑色素瘤和前列腺癌细胞侵袭具有不同的调节作用。
Oncotarget. 2016 Dec 6;7(49):81474-81492. doi: 10.18632/oncotarget.13034.
4
Targeting NF-κB in glioblastoma: A therapeutic approach.针对胶质母细胞瘤中的核因子κB:一种治疗方法。
Sci Adv. 2016 Jan 8;2(1):e1501292. doi: 10.1126/sciadv.1501292. eCollection 2016 Jan.
5
The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics.肿瘤坏死因子样弱凋亡诱导因子(TWEAK)受体Fn14是胶质母细胞瘤治疗药物靶向递送的潜在细胞表面通道。
Oncogene. 2016 Apr 28;35(17):2145-55. doi: 10.1038/onc.2015.310. Epub 2015 Aug 24.
6
All-trans retinoic acid impairs the vasculogenic mimicry formation ability of U87 stem-like cells through promoting differentiation.全反式维甲酸通过促进分化来损害U87干细胞样细胞的血管生成拟态形成能力。
Mol Med Rep. 2015 Jul;12(1):165-72. doi: 10.3892/mmr.2015.3449. Epub 2015 Mar 6.
7
New strategies in glioblastoma: exploiting the new biology.新策略治疗胶质母细胞瘤:挖掘新生物学。
Clin Cancer Res. 2015 May 1;21(9):1984-8. doi: 10.1158/1078-0432.CCR-14-1328. Epub 2015 Feb 10.
8
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.肿瘤坏死因子样凋亡微弱诱导剂(TWEAK)通过诱导NF-κB诱导激酶(NIK)和非经典NF-κB信号传导促进胶质瘤细胞侵袭。
Mol Cancer. 2015 Jan 27;14(1):9. doi: 10.1186/s12943-014-0273-1.
9
NF-κB, an active player in human cancers.NF-κB,人类癌症中的活跃参与者。
Cancer Immunol Res. 2014 Sep;2(9):823-30. doi: 10.1158/2326-6066.CIR-14-0112.
10
NF-κB inducing kinase, a central signaling component of the non-canonical pathway of NF-κB, contributes to ovarian cancer progression.核因子κB诱导激酶是核因子κB非经典途径的核心信号成分,它促进卵巢癌进展。
PLoS One. 2014 Feb 12;9(2):e88347. doi: 10.1371/journal.pone.0088347. eCollection 2014.